This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
Lausanne's startup ecosystem shows a strong concentration in deep tech sectors, particularly in biotechnology and artificial intelligence. This focus has drawn substantial venture capital to the Swiss city.
Biotech firm HAYA Therapeutics leads the pack with $1.1 billion in funding for its genetic medicine research. Other companies in areas from AI to robotics are also contributing to the city's growth.
Below is our list of 19 Lausanne startups worth keeping an eye on.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Corintis develops microfluidic cooling technology to directly cool data center chips. This approach improves chip performance and makes data centers more energy-efficient.
HAYA Therapeutics creates precision RNA-guided medicines that work by targeting the "dark genome," the non-coding regions of DNA. The company's platform discovers novel drug targets to develop treatments for fibrotic diseases and other serious health conditions.
Neural Concept builds an end-to-end platform that puts Engineering Intelligence at the core of the product development process. Their software uses AI and 3D deep learning to help engineering teams accelerate design cycles and create next-generation products.
Flybotix develops a collision-tolerant drone designed for inspecting confined indoor spaces. Their technology provides a safe and cost-effective way for industrial teams to access and assess hard-to-reach areas.
Debiopharm advances promising new drug candidates, from small molecules to biologics, through the development pipeline. The biopharmaceutical company in-licenses these potential therapies and shepherds them through clinical trials toward global market registration.
Largo.ai builds an AI-powered analytics platform that helps predict the success of movies. The system provides data-driven intelligence by analyzing scripts, proposing cast members, and forecasting a film's financial performance.
Hemostod has developed a process to manufacture platelets on-demand using engineered stem cells. This technology aims to provide a reliable and safe source for transfusions, solving the challenges of donor dependency and short shelf life.
Flyability builds collision-tolerant drones designed for safely inspecting confined and inaccessible spaces. Their flagship product, the Elios drone, allows industrial professionals to gather data in hazardous environments without risking human entry.
Giotto.ai builds a no-code AI platform that allows business experts to create, deploy, and manage predictive models. Their automated machine learning engine helps teams make data-driven decisions for use cases like lead scoring and predictive maintenance.
MindMaze builds a digital neurotherapeutics platform to help patients with treatment and rehabilitation for neurological conditions. Their technology provides a range of digital assessments and therapies, using tools like virtual reality to accelerate recovery.
Those top ten companies are just a small part of Lausanne's startup scene. Other founders are building companies in fields like biotech and AI, and together they have raised over $100 million.
Some of these companies are early in their journey, while others are further along. Here’s a look at the rest of the startups shaping Lausanne's ecosystem.
| Startup | Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
| Biotech | 2020 | $10.9M | Seed | |
| Other | 2024 | CHF159k | Grant | |
| Media | 2018 | CHF280k | Venture Round | |
| Fintech | 2015 | $7.6M | Series A | |
| AI | 2016 | CHF2.2M | Venture Round | |
| Biotech | 2010 | CHF26.6M | Grant | |
| Media | 2017 | $38.3M | Series B | |
| AI | 2018 | $8.9M | Seed | |
| Biotech | 2020 | $6M | Debt Financing |
